Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Shah Chetan
   2. Issuer Name and Ticker or Trading Symbol
AETHLON MEDICAL INC [AEMD] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
8910 UNIVERSITY CENTER LANE, SUITE 660		 3. Date of Earliest Transaction (Month/Day/Year)
10/20/2014
(Street)

SAN DIEGO, CA 92122		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/20/2014   A   666,667 A $ 0.093 11,920,633 D  
Common Stock 10/20/2014   A   333,333 A $ 0.096 12,253,966 D  
Common Stock 10/20/2014   A   1,111,111 A $ 0.108 13,365,077 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Purchase Warrant $ 0.093 10/20/2014   D     666,667 11/12/2012 11/12/2019 Common Stock 666,667 (1) 4,835,316 D  
Common Stock Purchase Warrant $ 0.093 10/20/2014   A   666,667   10/20/2014 10/20/2021 Common Stock 666,667 (1) 5,501,983 D  
Common Stock Purchase Warrant $ 0.096 10/20/2014   D     333,333 02/11/2013 02/11/2020 Common Stock 333,333 (1) 5,168,650 D  
Common Stock Purchase Warrant $ 0.096 10/20/2014   A   333,333   10/20/2014 10/20/2021 Common Stock 333,333 (1) 5,501,983 D  
Common Stock Purchase Warrant $ 0.108 10/20/2014   D     1,111,111 06/19/2012 06/19/2019 Common Stock 1,111,111 (1) 4,390,872 D  
Common Stock Purchase Warrant $ 0.108 10/20/2014   A   1,111,111   10/20/2014 10/20/2021 Common Stock 1,111,111 (1) 5,501,983 (2) D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Shah Chetan
8910 UNIVERSITY CENTER LANE, SUITE 660
SAN DIEGO, CA 92122		   X      

Signatures

 /s/ Chetan S. Shah   10/22/2014
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) In addition to the shares of Common Stock issued upon exercise of the warrant, Dr. Shah received a warrant to purchase the same number of shares of Common Stock at the same exercise price as the warrant that was exercised.
(2) In addition to the warrants reported on this form as being acquired by him, Dr. Shah also owns warrants to purchase Common Stock as follows: 937,500 shares at $0.125 per share, 534,723 shares at $0.12 per share, 333,333 shares at $0.115 per share, 333,333 shares at $0.121 per share and 1,251,983 shares at $0.132 per share.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.